This may be explained by the different depression definitions, with a more severe clinical definition used in Rivera et al. Another possible explanation could be that the observed interaction with the FTO gene may have been driven by the differential BMI distributions in depression cases and controls. The gene discussed is FTO; the disease is depressive symptom measurement.